The Week That Was: MRK Enters COVID Space, GSK's 1Bln Dose Target, Roche, GILD Team Up For REMDACTA

The week that just passed by saw some big names joining the race to develop vaccines for COVID-19, a couple of deals to speed up the manufacture of the vaccine and promising trial results of one of the potential COVID-19 treatments.

from RTT - Biotech https://ift.tt/3gCgKtL
via IFTTT

Pliant Therapeutics To Debut On Nasdaq On June 3

South San Francisco, California-based Pliant Therapeutics is slated to debut on the Nasdaq Global Market, under the symbol 'PLRX', on June 3, 2020. Founded in 2016, Pliant Therapeutics is a clinical stage biopharmaceutical company developing novel therapies for the treatment of fibrosis.

from RTT - Biotech https://ift.tt/2zJGDao
via IFTTT

Stock Alert: Canopy Growth Tumbles 18% On Earnings Miss, Uncertain Outlook

Shares of Canopy Growth Corp. (CGC, WEED.TO) are losing more than 18 percent or $3.94 in Friday's morning trade at $17.78 after the Canadian cannabis company's fourth-quarter results missed analysts' estimates. The stock has traded in a range of $9.00 to $44.17 in the past 52 weeks.

from RTT - Earnings https://ift.tt/3eu3F3O
via IFTTT

Stock Alert: Williams-Sonoma Hits New 52-week High

Shares of Williams-Sonoma Inc. (WSM) are rising more than 10 percent or $7.61 in Friday's morning trade at $80.64, after touching a new 52-week high of $80.95 earlier as the omni-channel specialty retailer's first-quarter results trumped analysts' estimates.

from RTT - Earnings https://ift.tt/2XNiJTA
via IFTTT

At The ASCO: ONCY, IMV, CRDF, GILD, TAK.

Here's a quick look at some of today's ASCO presentations.

from RTT - Biotech https://ift.tt/2XcJ9yG
via IFTTT

Stock Alert: Big Lots Stock Up 15% In Premarket On Stellar Q1 Results, Strong Q2 Outlook

Shares of Big Lots Inc. (BIG) are rising over 15% in pre-market today, after the company reported stellar Q1 results and issued strong Q2 earnings outlook. The stock has been trading in the range of $10.13 - $40.10 for the past one year, and closed Thursday's trade at $36.59, down $2.43 or 6.23%. BIG is currently trading at $42.11, up $5.52 or 15.09% in the pre-market session.

from RTT - Before the Bell https://ift.tt/3clnw3T
via IFTTT

AstraZeneca: IMFINZI Plus Tremelimumab Showed Promising Clinical Activity In HCC Patients

AstraZeneca Plc (AZN.L, AZN) said Friday that results from the global Phase II Study 22 trial testing the company's tremelimumab added to IMFINZI (durvalumab) demonstrated promising clinical activity and tolerability in patients with advanced hepatocellular carcinoma or HCC.

from RTT - Biotech https://ift.tt/3gDuqVw
via IFTTT

Apotex Recalls Diabetes Drug Metformin HCL Extended-Release Tablets

Apotex Corp. recalled all lots of type 2 diabetes medication Metformin hydrochloride in the form of oral film-coated tablets for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement.

from RTT - Biotech https://ift.tt/2zGGioV
via IFTTT

AstraZeneca Announces Results Of Updated Analysis Of Phase III CASPIAN Trial

AstraZeneca plc (AZN) announced Friday that detailed results from an updated analysis of the Phase III CASPIAN trial showed IMFINZI in combination with a choice of chemotherapies, etoposide plus either carboplatin or cisplatin, demonstrated a sustained, clinically meaningful overall survival (OS) benefit for adults with extensive-stage small cell lung cancer (ES-SCLC) treated in the 1st-line setting.

from RTT - Biotech https://ift.tt/3cfWKtA
via IFTTT

Pfizer, Astellas Say Final PROSPER Results Show XTANDI Extends Overall Survival

Pfizer Inc. (PFE) and Japan-based Astellas Pharma Inc. (ALPMY) on Friday announced final results from the overall survival or OS analysis of the Phase 3 PROSPER trial.

from RTT - Biotech https://ift.tt/2yNMcnQ
via IFTTT

Concerns About Trump Press Conference May Weigh On Wall Street

The major U.S. index futures are currently pointing to a lower opening on Friday, with stocks likely to extend the pullback seen late in the previous session.

from RTT - Market Analysis https://ift.tt/36ElXwA
via IFTTT

ABIO Jumps On Joining COVID-19 Drug Fray, GMAB Hits Trial Goal, IMRA On Watch

Today's Daily Dose brings you news about ARCA biopharma joining the battle against COVID-19; Genmab's positive results from amyloidosis trial; MacroGenics' regulatory update related to breast cancer drug candidate Margetuximab and Simulations Plus receiving the FDA grant award.

from RTT - Biotech https://ift.tt/2Al7c5y
via IFTTT

Stock Alert: Workday Rises 7%

Shares of Workday Inc. (WDAY) are up more than 7 percent or $12.67 in Thursday's morning trade at $183.05 after the company reported strong revenue growth for the first quarter despite a wider net loss.

from RTT - Earnings https://ift.tt/2M70Ut4
via IFTTT

Futures Pointing To Mixed Open On Wall Street

The major U.S. index futures are currently pointing to a mixed opening on Thursday, with the Dow futures up by 226 points but the Nasdaq futures are down by 72.25 points.

from RTT - Market Analysis https://ift.tt/2ZOIk0P
via IFTTT

Stock Alert: ARCA Biopharma Shares Soar 108% In Premarket AB201 Development Program News

Shares of ARCA biopharma Inc. (ABIO) are rising over 108% in pre-market today, after the company announced a new development program to evaluate AB201 (rNAPc2), a potent, selective inhibitor of tissue factor or TF, as a potential treatment for COVID-19 associated coagulopathy or CAC and the related inflammatory response.

from RTT - Before the Bell https://ift.tt/3c5p41C
via IFTTT

Dollar Tree Q1 Results Top Estimates; Does Not Issue Outlook

Discount store chain Dollar Tree, Inc. reported Thursday a profit for the quarter that declined from last year, due to lower gross margins, despite an 8.2 percent sales growth. Both adjusted earnings per share and quarterly net sales topped analysts' expectations. Further, the company did not issuing its updated guidance amid the ongoing COVID-19 pandemic.

from RTT - Earnings https://ift.tt/2M2G4Lk
via IFTTT

Cerecor Gets FDA Clearance For Clinical Trial Of CERC-002 In COVID-19 Induced ARDS

Biopharmaceutical company Cerecor Inc. (CERC) said Thursday it has received clearance from the U.S. Food and Drug Administration to proceed with a proof-of-concept clinical trial of its anti-LIGHT monoclonal antibody CERC-002 in patients with COVID-19 cytokine storm induced Acute Respiratory Distress Syndrome or ARDS.

from RTT - Biotech https://ift.tt/2TKLJtV
via IFTTT

Canadian Solar Withdraws FY20 Revenue Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Thursday, Canadian Solar Inc. (CSIQ) initiated revenue and module shipments outlook for the second quarter and maintained its full-year 2020 module shipments outlook.

from RTT - Earnings https://ift.tt/36NZQ77
via IFTTT

Triumph Group Suspends FY21 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the fourth quarter on Thursday, Triumph Group, Inc. (TGI) said it is not providing financial guidance for the full-year 2021 at this time, due to the uncertainty around the ultimate impact of COVID-19 on the global market and economic conditions.

from RTT - Earnings https://ift.tt/2yG0kiX
via IFTTT

PHAS To Begin COVID-19 Drug Trial In June, MRSN Hits New High, LJPC Plunges, RCUS On Watch

Today's Daily Dose brings you news about NantKwest teaming up with ImmunityBio to accelerate the development of vaccines and therapeutics for COVID-19; Mersana's promising data in ovarian cancer and non-small cell lung adenocarcinoma trial and Arcus' 10-year partnership with Gilead, among others.

from RTT - Biotech https://ift.tt/36AqqjG
via IFTTT

Amivas' Artesunate Gets FDA Approval As Only Drug In US To Treat Severe Malaria

The U.S. Food and Drug Administration granted approval for Artesunate for Injection 110 mg, powder and solvent for solution to biopharmaceutical company Amivas (US), LLC as the only FDA-approved drug now in the U.S. for the first-line treatment of severe malaria in adult and pediatric patients. It is also the first FDA-approved product that Amivas has introduced to their commercial portfolio.

from RTT - Biotech https://ift.tt/2AcBtUk
via IFTTT

Ralph Lauren Suspends Future Financial Guidance Amid COVID-19 - Quick Facts

While reporting its financial results for the fourth quarter on Wednesday, luxury fashion house Ralph Lauren Corp. (RL) said it is suspending all future guidance, due to the high level of uncertainty and evolving situation surrounding COVID-19 pandemic.

from RTT - Earnings https://ift.tt/36GQmKM
via IFTTT

European Commission Approves Bristol Myers' Zeposia - Quick Facts

Bristol Myers Squibb (BMY) announced Wednesday that the European Commission (EC) has approved Zeposia (ozanimod) for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease as defined by clinical or imaging features.

from RTT - Biotech https://ift.tt/3d8qFF9
via IFTTT

Photronics Guides Q3 EPS, Revenues In Line With Estimates - Quick Facts

While reporting financial results for the second quarter on Wednesday, semiconductor photomask maker Photronics, Inc. (PLAB) provided earnings and revenue guidance for the third quarter of fiscal 2020, in line with analysts' estimates.

from RTT - Earnings https://ift.tt/3eunSXn
via IFTTT

ARGX Soars On ADAPT Trial Data, MRK's Deals & Collaborations To Fight COVID-19, ALNY ON Watch

Today's Daily Dose brings you news about Alnylam Pharma's regulatory catalyst in December; argenx' generalized myasthenia gravis trial data; Atara's multiple sclerosis trial data and stock offering; Merck's deals and collaboration to develop an effective response to the COVID-19 pandemic; Novavax' progress in a COVID-19 vaccine trial and Osmotica Pharma's near-term catalysts.

from RTT - Biotech https://ift.tt/2ZAEloC
via IFTTT

Stock Alert: Mmtec Soars 106% On Annual Results

Shares of Mmtec, Inc. (MTC) more than doubled on Tuesday morning driven largely by the Chinese tech company's full-year financial reports.

from RTT - Earnings https://ift.tt/2X3lJfe
via IFTTT

Acella Pharma Recalls Thyroid Drug For Super Potency

The U.S. Food and Drug Administration or FDA announced that Acella Pharmaceuticals, LLC recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency. The company is recalling 13 lots of NP Thyroid that are packaged in 100 count bottles in strengths of 30 mg, 60 mg, and 90 mg, with expiration dates between June 20, 2020, and December 20, 2020.

from RTT - Biotech https://ift.tt/36x5gDl
via IFTTT

Stock Alert: Cellectar Shares Rally 34% In Premarket On FDA Fast Track Designation

Shares of Cellectar Biosciences Inc. (CLRB) are soaring over 34% in pre-market today, after the biopharmaceutical company announced that the U.S. FDA has granted Fast Track Designation for CLR 131 in lymphoplasmacytic lymphoma or LPL/Waldenstrom's macroglobulinemia or WM in patients having received two prior treatment regimens or more.

from RTT - Before the Bell https://ift.tt/2B3ouol
via IFTTT

Stock Alert: Novavax Begins Phase 1/2 Clinical Trial Of COVID-19 Vaccine; Stock Up 18% In Premarket

Shares of Novavax Inc. (NVAX) is soaring over 18% in pre-market today, after the biotechnology company announced the commencement of Phase 1/2 clinical trial of its COVID-19 vaccine.

from RTT - Before the Bell https://ift.tt/2M0FoX2
via IFTTT

Stock Alert: Argenx Shares Up 30% On Topline Data From Phase 3 ADAPT Trial Of Efgartigimod

Shares of argenx (ARGX) are rising over 30% in pre-market today, after the global immunology company announced positive topline data from the pivotal ADAPT trial of efgartigimod.

from RTT - Before the Bell https://ift.tt/3eczZrQ
via IFTTT

Hibbett Sports Not Providing FY21 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Tuesday, athletic-inspired fashion retailer Hibbett Sports Inc. (HIBB) reported that comparable store sales for the quarter grew 19.5 percent and e-commerce sales increased 110.5 percent.

from RTT - Earnings https://ift.tt/3gqWxa0
via IFTTT

Biotech Stocks Facing FDA Decision In June 2020

The FDA has been focusing mainly on COVID-19-related review since March. But that said, the regulatory decision on drugs proposed for rare tumors and life-threatening diseases has not been deferred. Now, let's take a look at the biotech stocks awaiting a regulatory decision in the month of June.

from RTT - Biotech https://ift.tt/2TDtTIZ
via IFTTT

The Week That Was: COVID-19 Drug/Vaccine Development Landscape

As the companies race against time to develop antibiotics or vaccines against the novel coronavirus, here's what happened in the COVID-19 drug/vaccine development space in the week that went by.

from RTT - Biotech https://ift.tt/2AX0d3g
via IFTTT

Brewers Carlsberg UK and Marston's announce merger

Smaller breweries warn deal could harm independent beer firms

Danish brewer Carlsberg and British pubs and cask ale firm Marston’s have announced a joint venture, prompting concern among small brewers who fear being squeezed out of the market.

Shares in Marston’s surged by 36%, recovering some of the value lost since Covid-19 lockdown shut pubs across the country, as investors applauded the tie-up.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2WRI9A2

Stock Alert: E.l.f Beauty Rises 10% On Upbeat Q4 Results

Shares of e.l.f. Beauty, Inc. (ELF) are gaining more than 10 percent or $1.49 in Friday's morning trade at $15.92 after the beauty company reported earnings and sales for the fourth quarter that beat analysts' expectations.

from RTT - Earnings https://ift.tt/2ZyYVWx
via IFTTT

Stock Alert: Foot Locker Down 8% After Weak Q1 Results

Shares of Foot Locker Inc. (FL) are losing more than 8 percent or $2.53 in Friday's morning trade at $26.79 after the specialty athletic retailer reported a net loss for the first quarter on a sharp decline in sales.

from RTT - Earnings https://ift.tt/2ZnSB3Y
via IFTTT

Futures Pointing To Mixed Open On Wall Street

The major U.S. index futures are currently pointing to a mixed opening on Friday, with stocks likely to show a lack of direction in early trading.

from RTT - Market Analysis https://ift.tt/2LNENHW
via IFTTT

Alibaba Q4 Adj. Profit Rises, Revenue Up 22%; Issues FY21 Guidance

Alibaba Group Holding Limited (BABA) reported fourth quarter non-GAAP earnings per share of RMB 1.15 or $0.16, an increase of 7% year-over-year. Non-GAAP earnings per ADS was RMB 9.20 or $1.30, an increase of 7%. On average, 25 analysts polled by Thomson Reuters expected the company to report profit per share of $0.87 for the quarter. Analysts' estimates typically exclude special items. Adjusted EBITDA increased 1% year-over-year to RMB 25.44 billion or $3.59 billion.

from RTT - Earnings https://ift.tt/36qM4Hk
via IFTTT

FDA Approves First Generic Version Of Vascepa; Amarin On Watch

Hikama Pharmaceutical LLC (HKMPY.OB) has received FDA approval to market its generic version of the brand drug Vascepa.

from RTT - Biotech https://ift.tt/2ZyDIf0
via IFTTT

Stock Alert: ZTO Express Falls 11% As Earnings Tumble

Shares of are ZTO Express (Cayman) Inc. (ZTO) are losing more than 11 percent or $3.86 in Thursday's morning trade at $30.42 after the company reported a 46 percent plunge in profit for the first quarter from last year. The stock has traded in a range of $17.12 to $35.64 in the past 52 weeks.

from RTT - Earnings https://ift.tt/3bSYloM
via IFTTT

Biota Biosciences Recalls Certain Lots Of Cannabidiol, Curcumin Injectables

Biota Biosciences recalled certain lots of pain suppressing medication Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin in the form of injectables as they were marketed without the approval of the U.S. Food and Drug Administration or FDA. Biota Biosciences is a supplier and contract manufacturer of wholesale, private label, and white label CBD Hemp Oil products.

from RTT - Biotech https://ift.tt/2ZoDQO9
via IFTTT

Stock Alert: IMV Shares Soar 20% In Premarket

Shares of IMV Inc. (IMV) are surging over 20% in pre-market today, after the company announced selection of a vaccine candidate against COVID-19 to advance into human clinical studies.

from RTT - Before the Bell https://ift.tt/2APN5wL
via IFTTT

TJX Slips To Loss In Q1, Net Sales More Than Halve

The TJX Companies Inc. (TJX) Thursday reported a loss for the first quarter, compared to profit in the prior year. Quarterly net sales dropped 52.5 percent, hurt by the temporary closure of its stores due to the Covid-19 pandemic. The company expects very strong initial sales overall at stores across all states and countries that have been reopened at least a week.

from RTT - Earnings https://ift.tt/2LMbVzJ
via IFTTT

Profit Taking May Contribute To Initial Weakness On Wall Street

The major U.S. index futures are currently pointing to a modestly lower opening on Thursday, with stocks likely to give back some ground following the strong upward move seen in the previous session.

from RTT - Market Analysis https://ift.tt/2AGvfft
via IFTTT

Stock Alert: Kadmon Shares Up 11% In Premarket On Pivotal Trial Data Of KD025

Shares of Kadmon Holdings Inc. (KDMN) are rising over 11% in pre-market today, after the company announced positive topline results from the primary analysis of ROCKstar (KD025-213), the pivotal trial evaluating belumosudil (KD025) in patients with chronic graft-versus-host disease (cGVHD) who have received at least two prior lines of systemic therapy.

from RTT - Before the Bell https://ift.tt/36knaJg
via IFTTT

Brady Corp. Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the third quarter on Thursday, identification solutions provider Brady Corp. (BRC) said it is withdrawing its previously communicated financial guidance for the full-year 2020, due to the evolving and uncertain impact of the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/36gvRV1
via IFTTT

Best Buy Not Providing Outlook; Declared Dividend - Quick Facts

While reporting financial results for the first quarter on Thursday, electronics retailer Best Buy Co., Inc. (BBY) said it is not providing any financial guidance now as it had suspended all financial guidance for the full-year 2021 on March 21, due to the uncertainty related to the ongoing COVID-19 pandemic.

from RTT - Earnings https://ift.tt/2XilMCF
via IFTTT

BJ's Wholesale Club Q1 Results Top Estimates - Quick Facts

BJ's Wholesale Club Holdings Inc. (BJ) announced Thursday that net income for the first quarter soared to $95.73 million or $0.69 per share from $35.80 million or $0.25 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/3g7foH3
via IFTTT

Hormel Foods Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the second quarter on Thursday, branded food company Hormel Foods Corp. (HRL) said it is withdrawing its previously communicated earnings and sales guidance for the full-year 2020, due to uncertainty regarding the impact of COVID-19.

from RTT - Earnings https://ift.tt/2TldgSr
via IFTTT

Will Data From Liver Disease, Sickle Cell Disease Trials Give Axcella A Boost?

Shares of Axcella Health Inc. (AXLA) have been dismally performing since their listing on the NASDAQ on May 9, 2019. The stock is down more than 70 percent over the last 1 year.

from RTT - Biotech https://ift.tt/2TpubTW
via IFTTT

Investec FY Pre-tax Profit From Cont. Ops. Declines - Quick Facts

Investec plc (INVP.L) on Thursday reported pre-tax profit from continuing operations of 310.48 million pounds for the year ended 31 March 2020, down from 514.53 million pounds in the prior year. Earnings per share from continuing operations were 17.5 pence, down from 40.4 pence last year.

from RTT - Earnings https://ift.tt/3e6usmB
via IFTTT

Inchcape 4-month Group Revenue Down 32% - Quick Facts

Inchcape Plc (INCH.L), a multi-brand automotive distributor and retailer, said Thursday in a trading update that for the four-month period from January 1 to April 30, 2020, Group revenue declined 32 percent on a reported basis to 2.1 billion pounds.

from RTT - Earnings https://ift.tt/2zVHW5M
via IFTTT

Whitbread FY20 Pre-tax Profit Rises; Says COVID-19 To Impact FY21 Earnings

British restaurant company Whitbread plc (WTB.L) reported Thursday that its fiscal 2020 profit before tax rose 28.4 percent to 280 million pounds from a restated 218 million pounds in the prior year.

from RTT - Earnings https://ift.tt/2zXUp8W
via IFTTT

Inari Medical To Make U.S. Trading Debut On May 22

Irvine, California-based Inari Medical is slated to debut on the Nasdaq Global Select Market, under the symbol 'NARI', on May 22, 2020.

from RTT - Biotech https://ift.tt/3e6uSti
via IFTTT

ATRA Abuzz, ATOS' COVID-19 Med Effective, INO And VXRT On Track

Today's Daily Dose brings you news about the near-term catalyst of Atara; promising lab study results of Atossa's COVID-19 med; the progress in Gilead/Galapagos' ulcerative colitis trial; the timeline of Inovio's COVID-19 vaccine and the progress in Vaxart's COVID-19 vaccine program.

from RTT - Biotech https://ift.tt/3cRAOG6
via IFTTT

Inovio Pharma: What's The Buzz?

Inovio Pharmaceuticals Inc. (INO), one of the key players in the race to develop a COVID-19 vaccine, has revealed promising data from a preclinical study of INO-4800, its DNA vaccine candidate against the novel coronavirus SARS-CoV-2, which causes COVID-19.

from RTT - Biotech https://ift.tt/2WLQHIA
via IFTTT

Stock Alert: Surface Oncology Shares Up 36% In Premarket

Shares of Surface Oncology (SURF) are up over 36% in pre-market today, after the company announced that it has entered into a clinical trial collaboration with Merck (MRK), known as MSD outside the United States and Canada, through a subsidiary, to evaluate the safety and efficacy of combining Surface's SRF617, an investigational antibody therapy targeting CD39, with Merck's KEYTRUDA (pembrolizumab), the first anti-PD-1 therapy approved in the United States.

from RTT - Before the Bell https://ift.tt/3cOv3Jp
via IFTTT

U.S. Stocks Likely To Move Back To The Upside After Late-Day Pullback

The major U.S. index futures are pointing to a significantly higher open on Wednesday, with stocks likely to move back to the upside following the sharp pullback seen late in the previous session.

from RTT - Market Analysis https://ift.tt/2WRrsox
via IFTTT

Stock Alert: INOVIO Shares Up 14% In Premarket On COVID-19 Vaccine DNA Data

Shares of INOVIO (INO) are rising over 14% in pre-market today, after the company announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA vaccine, demonstrating robust neutralizing antibody and T cell immune responses against coronavirus SARS-CoV-2.

from RTT - Before the Bell https://ift.tt/2ToSe5f
via IFTTT

Stock Alert: KindredBio Stock Up 16% On COVID-19 Vaccine Development News

Shares of Kindred Biosciences Inc. (KIN) are rising over 16% in pre-market today, after the company the biopharmaceutical company announced an agreement with Vaxart Inc. (VXRT) for the manufacture of Vaxart's oral vaccine candidate for COVID-19.

from RTT - Before the Bell https://ift.tt/2LMkY3P
via IFTTT

Royal Caribbean Sees Loss In Q2, FY20 - Quick Facts

While reporting its first-quarter financial results on Wednesday, Royal Caribbean Cruises Ltd. (RCL) also provided a business update in light of the impact of the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/3g85Hs0
via IFTTT

Analog Devices Guides Q3 In Line With Estimates, Declares Dividend - Quick Facts

While reporting financial results for the second quarter on Wednesday, analog technology company Analog Devices Inc. (ADI) provided earnings and revenue guidance for the third quarter, in line with analysts' expectations.

from RTT - Earnings https://ift.tt/2yjAYHt
via IFTTT

FDA OKs Myriad's BRACAnalysis CDx Test As Companion Diagnostics For Lynparza

Molecular diagnostics company Myriad Genetics, Inc. (MYGN) announced Wednesday that the U.S. Food and Drug Administration (FDA) approved its BRACAnalysis CDx test for use as a companion diagnostic by healthcare professionals to identify men with metastatic castration-resistant prostate cancer (mCRPC) who are eligible for treatment with Lynparza (olaparib).

from RTT - Biotech https://ift.tt/2LLDFVm
via IFTTT

Daqo New Energy Maintains FY20 Production Outlook - Quick Facts

While reporting financial results for the first quarter on Wednesday, Daqo New Energy Corp. (DQ), a manufacturer of high-purity polysilicon for the global solar PV industry, announced polysilicon production and sales guidance for the second quarter and maintained its full-year 2020 polysilicon production guidance.

from RTT - Earnings https://ift.tt/2AGp3nH
via IFTTT

McKesson Guides FY21 Adj. EPS Below Analysts' Expectations - Quick Facts

While reporting financial results for the fourth quarter on Wednesday, healthcare company McKesson Corp. (MCK) initiated adjusted earnings and revenue growth guidance for the full-year 2021.

from RTT - Earnings https://ift.tt/2WO9gvM
via IFTTT

Target Q1 Adj. EPS Miss Estimates, But Revenues Top

Retailer Target Corp. reported Wednesday a sharp 64 percent drop in profit for the first quarter, reflecting the impact of rapidly-evolving shopping patterns and significant investments in response to the COVID-19 pandemic. Adjusted net earnings for the quarter missed analysts' expectations, while revenues topped it.

from RTT - Earnings https://ift.tt/3e0KVIW
via IFTTT

Lowe's Withdraws FY20 Outlook Amid COVID-19; Q1 Results Top Estimates

While reporting financial results for the first quarter on Wednesday, home improvement retailer Lowe's Cos., Inc. (LOW) said it is withdrawing its previously communicated financial guidance for the full-year 2020, due to the limited visibility into future business trends in this unprecedented operating environment amid the COVID-19 outbreak.

from RTT - Earnings https://ift.tt/3g5qRHh
via IFTTT

Marks And Spencer FY Pretax Profit Declines; Revenue Down 1.9% - Quick Facts

Marks and Spencer Group Plc (MAKSY.PK, MAKSF.PK, MKS.L) reported profit before tax of 67.2 million pounds for 52 weeks ended 28 March 2020 compared to 84.2 million pounds, prior year. Earnings per share was 1.2 pence compared to 2.4 pence. Profit before tax included an estimated total impact of 264.7 million pounds for Covid-19. Profit before tax & adjusting items declined 21.2 percent to 403.1 million pounds. Adjusted earnings per share was 16.6 pence compared to 23.6 pence. The Group noted that its profit before tax & adjusting items for the fiscal year included an adverse profit impact of approximately 52 million pounds in March which is largely attributed to Covid-19.

from RTT - Earnings https://ift.tt/36dlPUq
via IFTTT

ADCT Closes IPO, ALDX To Provide COVID-19 Update, RWLK To Focus On Telehealth

Today's Daily Dose brings you news about ADC Therapeutics' IPO; Aldeyra Therapeutics' COVID-19 drug development update; Bio-Techne's plan to ramp up COVID-19 Test Kit production; ReWalk's telehealth opportunities; after-hours movers and the latest on the number of coronavirus cases.

from RTT - Biotech https://ift.tt/2zhgfEq
via IFTTT

Stock Alert: Sina Jumps 9%

Shares of Sina Corp. (SINA) gained nearly 9% on Tuesday morning after the Chinese online company's first-quarter earnings and revenues trumped Wall Street estimates.

from RTT - Earnings https://ift.tt/3cKVYpz
via IFTTT

Traders May Show Caution Following Yesterday's Rally

The major U.S. index futures are currently pointing to a mixed open on Tuesday, with stocks likely to show a lack of direction following the rally seen in the previous session.

from RTT - Market Analysis https://ift.tt/3eczqhR
via IFTTT

Darden Restaurants Q4 To Date Same-restaurant Sales Down 47.9%

Darden Restaurants, Inc., (DRI) provided a business update on Tuesday, saying that its same-restaurant sales for the fourth quarter to date through Sunday, May 17, declined 47.9 percent.

from RTT - Earnings https://ift.tt/3bMGRKG
via IFTTT

Walmart Q1 Profit Tops Estimates; Withdraws FY21 Outlook - Quick Facts

Walmart (WMT) reported first quarter adjusted earnings per share of $1.18, up 4.4% from prior year. On average, 25 analysts polled by Thomson Reuters expected the company to report profit per share of $1.17, for the quarter. Analysts' estimates typically exclude special items.

from RTT - Earnings https://ift.tt/2ZphLiq
via IFTTT

Kohl's Begins Rebuilding Process, Reopening About 50% Stores - Quick Facts

While reporting financial results for the first quarter on Tuesday, retailer Kohl's Corp. (KSS) said it has begun the rebuilding process, recently reopening about 50 percent of its stores across the country. In doing so, the company has taken special care to equip its stores with the latest health and safety measures as it welcomes back its associates and customers.

from RTT - Earnings https://ift.tt/2WHOtdo
via IFTTT

Advance Auto Parts Not Providing Guidance Now Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Tuesday, automotive aftermarket parts provider Advance Auto Parts Inc. (AAP) said it is not providing guidance at this time given uncertainties related to the full impact of the COVID-19 pandemic. The company had withdrawn its full year 2020 guidance on April 9, 2020.

from RTT - Earnings https://ift.tt/2LHGZk8
via IFTTT

Home Depot Suspends FY20 Outlook Amid COVID-19; Declares Dividend - Quick Facts

While reporting financial results for the first quarter on Tuesday, home improvement retailer Home Depot, Inc. (HD) said it is suspending its previously communicated financial guidance for fiscal 2020 as a result of the uncertainty related to the duration of COVID-19 and its impact on the broader economy.

from RTT - Earnings https://ift.tt/3dXeV8y
via IFTTT

ABUS Up On HBV Trial Data, VIR's COVID-19 Therapies On Track, All Eyes On DVAX

Today's Daily Dose brings you news about positive results from Arbutus' HBV trial; encouraging phase I results of Moderna's COVID-19 vaccine candidate; biotech stocks hitting new highs and Vir Biotechnology's progress in the battle against the novel coronavirus.

from RTT - Biotech https://ift.tt/3bLlp93
via IFTTT

Summitt Labs Recalls Kore Organic Watermelon CBD Oil

Summitt Labs voluntarily recalled one lot of Kore Organic Watermelon CBD oil tincture to the consumer level after the product was found to contain high levels of lead. Ingestion of the oil tincture containing lead could result in high lead exposure and acute lead poisoning. The company issued the nationwide recall for Batch#730 Lot#K018 of the Kore organic watermelon CBD oil tincture.

from RTT - Biotech https://ift.tt/2WFkvGT
via IFTTT

Stock Alert: Aurora Cannabis Surges 41% On Revenue Growth

Shares of Aurora Cannabis Inc. (ACB) are gaining more than 41 percent or $4.63 in Monday's morning trade at $15.83 after the company reported strong revenue growth in the third quarter. The stock has traded in a range of $5.30 to $105.48 in the past 52 weeks.

from RTT - Earnings https://ift.tt/36aojmq
via IFTTT

Optimism About Coronavirus Vaccine May Generate Early Buying Interest

The major U.S. index futures are currently pointing to a higher opening on Monday, with stocks likely to add to the gains posted in the two previous sessions.

from RTT - Market Analysis https://ift.tt/368mCWE
via IFTTT

FDA Halts Bill Gates-backed Coronavirus Testing Program

The Food and Drug Administration has halted an at-home coronavirus testing program by Seattle Coronavirus Assessment Network or SCAN, which is backed by Bill Gates, for lack of proper approval. In an update of the project on its website, SCAN said its testing of home-based, self-collected samples for COVID-19 is currently paused after the FDA notified that a separate federal emergency use authori

from RTT - Biotech https://ift.tt/2WIyYln
via IFTTT

Stock Alert: JD.com Shares Hit 52-Week High

Shares of JD.com Inc. (JD) hit a 52-week high of $51.01 on Friday, May 15, before closing at $50.85, up $1.89 or 3.86%. The stock has been trading in the range of $25.48 - $51.01 for the past one year, and is currently trading at $51.82, up $0.97 or 1.91% in the pre-market session.

from RTT - Before the Bell https://ift.tt/3g1QCIw
via IFTTT

Peekaboo Mint Chocolate Chip Ice Cream Sold Through Target Recalled

Ramar Foods is recalling one flavor of Peekaboo ice cream sold through Target stores in four states, citing possible presence of Listeria monocytogenes, the U.S. Food and Drug Administration said in a statement. The recall involves 14 ounce packages of Peekaboo branded Mint Chocolate Chip with Hidden Spinach Ice Cream product.

from RTT - Biotech https://ift.tt/2Tich5l
via IFTTT

Stock Alert: Alta Equipment Stock Jumps 20%

Shares of Alta Equipment Group Inc. (ALTG) are currently up over 20% on Friday morning, driven largely by higher first-quarter revenues.

from RTT - Earnings https://ift.tt/3cBgfh1
via IFTTT

Stock Alert: Bridgeline Digital Jumps 92% After Quarterly Results

Shares of Bridgeline Digital, Inc. (BLIN) are surging more than 92 percent or $1.15 in Friday's morning trade at $2.39 after the company reported a turnaround to profit in the second quarter. The stock has traded in a range of $0.53 to $6.00 in the past 52 weeks.

from RTT - Earnings https://ift.tt/2T9tVIn
via IFTTT

Stock Alert: Theratechnologies Stock Up 22% In Premarket

Shares of Theratechnologies Inc. (THTX) are rising over 22% in pre-market today, the company announced new positive results for its investigational Sortilin or SORT1 targeting peptide-drug conjugates, which will be presented in three posters during AACR's virtual annual meeting II on June 22, 2020.

from RTT - Before the Bell https://ift.tt/2LBH74x
via IFTTT

Futures Pointing To Sharply Lower Open On Wall Street

The major U.S. index futures are currently pointing to a sharply lower opening on Friday, with stocks likely to move back to the downside following the substantial rebound seen over the course of the previous session.

from RTT - Market Analysis https://ift.tt/2yOKZwB
via IFTTT

Stock Alert: Futu Holdings Up 7% After Q1 Profit Jumps

Shares of Futu Holdings Limited, an online brokerage and wealth management platform in China, are rising more than 7 percent or $0.92 in Thursday's morning trade at $13.20 after reporting a surge in profit for the first quarter from last year. The stock has traded in a range of $8.16 to $14.20 in the past 52 weeks.

from RTT - Earnings https://ift.tt/3bt7wMJ
via IFTTT

Chinese threat prompts calls for UK to toughen company takeover laws

Minsters want national security measure after failed boardroom coup at technology firm

An aborted Chinese-led boardroom coup at a British technology firm is set to force the UK government to adopt stronger intervention powers to prevent hostile countries taking major stakes in strategic UK businesses.

The coup, involving putting four Chinese government-backed members on to the board of Imagination Technologies, has led Tory backbenchers to demand ministers toughen pre-existing plans to add a stronger national security element to UK takeover laws.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2zE93C6

Stock Alert: AIM ImmunoTech Shares Jump 30% In Premarket

Shares of AIM ImmunoTech Inc. (AIM) are rising over 30% in pre-market today, after the company announced that the U.S. FDA has authorized the first human trial assessing the safety and effectiveness of the company's lead asset, Ampligen (rintatolimod), in combination with interferon alfa-2b, in cancer patients with COVID-19, the disease caused by the SARS-CoV-2 coronavirus.

from RTT - Before the Bell https://ift.tt/2Z1L1vJ
via IFTTT

Renewed Concerns About Economy May Weigh On Wall Street

The major U.S. index futures are currently pointing to a sharply lower opening on Thursday, with stocks likely to extend the sell-off seen over the two previous sessions.

from RTT - Market Analysis https://ift.tt/2Z1jOcs
via IFTTT

Stock Alert: Applied DNA Stock Up 81% On EUA For Linea COVID-19 RT-PCR Test

Shares of Applied DNA Sciences Inc. (APDN) are surging over 81% in pre-market today, after the company announced that the U.S. FDA has provided Emergency Use Authorization or EUA for the clinical use of the company's patent-pending Linea COVID-19 RT-PCR test for COVID-19.

from RTT - Before the Bell https://ift.tt/3cB8MyA
via IFTTT

Entercom Communications Slips To Loss In Q1; Revenue Declines - Quick Facts

Entercom Communications Corp. (ETM), a media and entertainment company, on Thursday reported net loss for the first quarter of $9.14 million or $0.07 per share, compared to net income of $3.13 million or $0.02 per share in the year-ago period.

from RTT - Earnings https://ift.tt/2WYiBjB
via IFTTT

Norwegian Cruise Line Q1 Adj. Loss Wider Than Estimates, But Revenue Beats

Norwegian Cruise Line Holdings Ltd. (NCLH) reported Thursday that its net loss for the first quarter was $1.88 billion or $8.80 per share, compared to net income of $118.16 million or $0.54 in the prior-year quarter.

from RTT - Earnings https://ift.tt/3cwCcxR
via IFTTT

Brookfield Asset Management Slips To Loss In Q1 - Quick Facts

Brookfield Asset Management Inc. (BAM, BAM-A.TO) on Thursday reported a net loss for the first quarter attributable to shareholders of $157 million or $0.20 per share, compared to net income of $1.26 billion or $0.39 per share in the year-ago quarter.

from RTT - Earnings https://ift.tt/2yV7hN5
via IFTTT

Wabash National Slips To Loss In Q1 - Quick Facts

Wabash National Corp. (WNC) reported Thursday a net loss for the first quarter of fiscal 2020 of $106.65 million or $2.01 per share, compared to net income of $14.78 million or $0.27 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/3bCtWLC
via IFTTT

3M April Total Sales Decline 11% - Quick Facts

3M Co. (MMM) reported Thursday that total sales for the month of April 2020 declined 11 percent year-on-year to $2.3 billion.

from RTT - Earnings https://ift.tt/2LqWdtJ
via IFTTT

Merck KGaA Q1 Profit Climbs, Cuts FY20 View Due To Covid-19; Stock Down

Shares of Merck KGaA were losing around 2 percent in the morning trading in Germany after the science and technology company on Thursday lowered its forecast for fiscal 2020 hurt by Covid-19 crisis, despite reporting strong first-quarter results. Merck said the Covid-19 crisis only had a moderate impact in the first quarter, but the effects would amplify in the coming months.

from RTT - Earnings https://ift.tt/2WNwvEU
via IFTTT

China Automotive Systems Initiates FY20 Revenue Guidance - Quick Facts

While reporting financial results for the fourth quarter on Thursday, China Automotive Systems, Inc. (CAAS) initiated revenue guidance for the full-year 2020 of $360 million, based on the company's current views on operating and market conditions, which are subject to change.

from RTT - Earnings https://ift.tt/35WvSxf
via IFTTT

For Your Eyes: Kala Pharma (KALA) Hits New High

Shares of Kala Pharmaceuticals Inc. (KALA) touched a new 52-week high of $12.51 in intraday trading yesterday, before closing at $12.01.

from RTT - Biotech https://ift.tt/3fG05F4
via IFTTT

WH Smith H1 Pretax Profit Down 3%; Revenue Rises - Quick Facts

WH Smith plc (SMWH.L) reported Thursday that its statutory Group profit before tax for the six months ended 29 February 2020 was 63 million pounds, down 3 percent from 65 million pounds in the ye-ago period. Earnings per share declined 12 percent to 41.2 pence from 46.8 pence last year.

from RTT - Earnings https://ift.tt/3dE5zyc
via IFTTT

SGL Carbon Slips To Loss In Q1; Sees Negative Group Recurring EBIT In Q2

German carbon and graphite product manufacturer SGL Carbon (SGLFF.PK) reported Thursday that its consolidated net loss for the first quarter attributable to shareholders of the parent company was 4.3 million euros, compared to net income of 8.9 million euros in the year-ago period. Loss per share was 0.04 euros, compared to earnings of 0.07 euros per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/2ArEFLU
via IFTTT

Fraport Says Frankfurt Airport April Passenger Traffic Down 96.9%

Fraport AG (FRA.DE, 0O1R.L, FPRUF.PK), the owner and operator of Germany's Frankfurt Airport or FRA, said Thursday that Frankfurt Airport served only about 188,078 passengers in April 2020, down 96.9 percent from the year-ago period.

from RTT - Earnings https://ift.tt/3fLlKf6
via IFTTT

SMA Solar Technology Q1 EBITDA, Sales Rise; Confirms FY20 Outlook

Solar energy equipment supplier SMA Solar Technology AG (SMTGF.PK) reported Thursday that its net income broke even in the first quarter, compared to net loss of 10.6 million euros last year. Loss per share narrowed to 0.0.1 euros from 0.30 euros a year ago.

from RTT - Earnings https://ift.tt/3fMXzgp
via IFTTT

FDA Snubs BMY And BLUE, Stocks That Moved On ASCO Abstracts (ARVN, CTMX, MGNX)

Today's Daily Dose brings you news about the status of Bristol Myers and bluebird bio's Idecabtagene vicleucel Biologics License Application and the companies that have released Abstracts for the ASCO 2020 Virtual Meeting and their stock movement.

from RTT - Biotech https://ift.tt/2Z2wccm
via IFTTT

Stock Alert: Varex Imaging Tanks Nearly 30% Following Q2 Results

Shares of Varex Imaging Corporation (VREX) are currently losing nearly 30% on Wednesday morning. The company reported second-quarter net loss. On adjusted basis, earnings and revenues fell short of Wall Street view.

from RTT - Earnings https://ift.tt/2Z0WmMC
via IFTTT

Stock Alert: PGT Innovations Jumps 21% As Q1 Results Beat Estimates

Shares of are PGT Innovations, Inc. (PGTI), a manufacturer of impact-resistant residential windows and doors, are gaining more than 21 percent or $2.10 in Wednesday's morning trade at $11.87 after the company's financial results for the first quarter beat analysts' estimates. The stock has traded in a range of $6.88 to $18.48 in the past 52 weeks.

from RTT - Earnings https://ift.tt/2AkdHpf
via IFTTT

Stock Alert: PGT Innovations Stock Up 15% In Premarket

Shares of PGT Innovations Inc. (PGTI) are rising over 15% in pre-market today, following the company's upbeat Q1 results.

from RTT - Before the Bell https://ift.tt/3cwYrUu
via IFTTT

Tech Stocks May Help Lead Rebound On Wall Street

The major U.S. index futures are pointing to a higher open on Wednesday, with stocks likely to regain ground following the sell-off seen late in the previous session.

from RTT - Market Analysis https://ift.tt/2yK973v
via IFTTT

Galaxy Entertainment Q1 Revenue Plunges 61% Amid COVID-19 - Quick Facts

Reporting selected unaudited financial data for the first quarter on Wednesday, Hong Kong-based Galaxy Entertainment Group Ltd. (GXYEF.PK, GXYEY.PK) said its adjusted EBITDA for the quarter plunged 93 percent to HK$283 million from HK$3.98 billion last year.

from RTT - Earnings https://ift.tt/3cuHrhw
via IFTTT

ADC Therapeutics Relaunching IPO Tomorrow

Epalinges, Switzerland-based ADC Therapeutics is scheduled to list its stock on the NYSE, under the symbol 'ADCT', on May 14, 2020. This is the second attempt of the company to go public. ADC Therapeutics, which is a spinoff from Spirogen Ltd., had withdrawn its IPO filing in September 2019, citing adverse market conditions.

from RTT - Biotech https://ift.tt/3fGzLuJ
via IFTTT

Commerzbank Slips To Q1 Loss, Sees Stable Customer Business Revenue; Stock Down

Shares of Commerzbank AG were losing around 5 percent in the morning trading in Germany after the banking major reported Wednesday a loss in its first quarter, compared to prior year's profit, hurt mainly by impacts from coronavirus or Covid-19 pandemic. Revenues declined, while net interest income increased with strong customer business. Looking ahead, the Bank expects to keep revenue in customer

from RTT - Earnings https://ift.tt/2y2HKBi
via IFTTT

ARPO Soars, GNFT's NASH Study Fails, Moderna's COVID-19 Vaccine On Fast Track

Today's Daily Dose brings you news about Aerpio Pharma's amended licensing deal with Gossamer Bio; Gamida's encouraging results from phase III study of Omidubicel malignancies; Genfit's disappointing NASH trial results; Fast Track designation for Moderna's mRNA vaccine against the novel coronavirus and NanoViricides' progress in the COVID-19 drug development program.

from RTT - Biotech https://ift.tt/3fTouY2
via IFTTT

Simon Properties Reopens 77 Retail Properties

Simon Property Group, the biggest mall owner in the U.S., has reopened 77 of its U.S. retail properties that were temporarily closed in March in response to the coronavirus pandemic and said it is encouraged by the customer response so far. The company also reported a 20 percent decrease in its profit for the first quarter from last year.

from RTT - Earnings https://ift.tt/3fE1ps6
via IFTTT

Stock Alert: Eventbrite Shares Fall 16%

Shares of Eventbrite, Inc. (EB) are currently down more than 16% after the event-management services company's first-quarter revenues and profit missed Wall Street estimates.

from RTT - Earnings https://ift.tt/3fHZd2L
via IFTTT

Stock Alert: Celsius Jumps 26% After Q1 Results

Shares of Celsius Holdings, Inc. (CELH), a provider of functional calorie-burning fitness beverages, are rising more than 26 percent or $1.43 in Tuesday's morning trade at $6.90 after its first-quarter results beat analysts' estimates. The stock has traded in a range of $3.06 to $7.14 in the past 52 weeks.

from RTT - Earnings https://ift.tt/3dIFU7P
via IFTTT

Stock Alert: SII-VI Jumps Nearly 30%

Shares of SII-VI Incorporated (IIVI) are currently up nearly 30% on Tuesday morning after the company reported third-quarter profit that topped Wall Street estimates. The company's outlook for the fourth quarter is expected to beat current expectations.

from RTT - Earnings https://ift.tt/2SXug0U
via IFTTT

Stock Alert: Datadog Climbs 13% On Upbeat Q1 Results

Shares of Datadog Inc. (DDOG) are gaining more than 13 percent or $7.50 in Tuesday's morning trade at $63.19 after the company reported a turnaround to profit in the first quarter on strong revenue growth. The stock has traded in a range of $27.55 to $64.34 in the past 52 weeks.

from RTT - Earnings https://ift.tt/2Lm84sX
via IFTTT

Continued Optimism About Reopening May Lead To Strength On Wall Street

The major U.S. index futures are currently pointing to a higher open on Tuesday following the mixed performance seen in the previous session.

from RTT - Market Analysis https://ift.tt/2zy2np4
via IFTTT

Stock Alert: Novavax Shares Up 51% In Premarket On $384 Mln Addl. Funding News

Shares of Novavax Inc. (NVAX) are rising over 51% in pre-market today, after the company announced that the Coalition for Epidemic Preparedness Innovations or CEPI would invest up to $384 million of additional funding, on top of $4 million it invested in March, to advance clinical development of NVX-CoV2373, Novavax' coronavirus vaccine candidate against SARS-CoV-2.

from RTT - Before the Bell https://ift.tt/2LofXy0
via IFTTT

Stock Alert: Gamida Cell Shares Surge 60% In Premarket

Shares of Gamida Cell Ltd. (GMDA) are soaring over 60% in pre-market today, after the company announced positive topline results from its Phase 3 clinical study evaluating the safety and efficacy of omidubicel, an investigational advanced cell therapy in development as a potential life-saving treatment option for patients in need of bone marrow transplant.

from RTT - Before the Bell https://ift.tt/2AnkJd5
via IFTTT

Stock Alert: NanoViricides Stock Up 37% In Premarket

Shares of NanoViricides Inc. (NNVC) are rising over 37% in pre-market today, after the company announced that it has developed drug candidates that have demonstrated very high anti-viral effectiveness in cell culture studies against multiple coronaviruses.

from RTT - Before the Bell https://ift.tt/2xU4ymv
via IFTTT

Dynatrace Guides Q1, FY21 Adj. EPS Above Estimates - Quick Facts

While reporting financial results for the fourth quarter on Tuesday, software intelligence provider Dynatrace, Inc. (DT) initiated its adjusted earnings and revenue guidance for the full-year 2021 and provided outlook for the first quarter.

from RTT - Earnings https://ift.tt/3cwpFus
via IFTTT

MyoKardia (MYOK) Joins $100 Stock Price Club

Shares of MyoKardia Inc. (MYOK) touched an all-time high of $104.26 in intraday trading on Monday, before closing at $96.90, thanks to positive top-line data from the Company's phase III EXPLORER study of Mavacamten for the treatment of obstructive hypertrophic cardiomyopathy.

from RTT - Biotech https://ift.tt/2AdZYjM
via IFTTT

Allianz Stock Dips On Weak Q1 Profit, AuM

Shares of Allianz SE were losing around 3 percent in German trading after the insurance and asset management company reported Tuesday weak profit in its first quarter due to higher claims from natural catastrophes and COVID-19-related losses in the Property-Casualty business, despite higher revenues. The company, which withdrew its fiscal 2020 operating profit outlook last week, now said a new ...

from RTT - Earnings https://ift.tt/2WrB7BY
via IFTTT

The Rise And Rise Of Novavax (NVAX)

Shares of Novavax Inc. (NVAX) jumped 30 percent in Monday's regular trading and gained nearly 40 percent in after-hours, following significant progress in the Company's influenza and COVID-19 vaccine programs and increased funding from the Coalition for Epidemic Preparedness Innovations.

from RTT - Biotech https://ift.tt/35Q61qA
via IFTTT

Stock Alert: Revolve Group Gains 12%

Shares of Revolve Group Inc. (RVLV), an online fashion retailer, are rising more than 12 percent or $1.62 in Monday's morning trade at $14.65 despite the absence of any stock-specific news. The stock has traded in a range of $7.17 to $48.36 in the past 52 weeks.

from RTT - Earnings https://ift.tt/2WNKrPc
via IFTTT

Stock Alert: Avaya Holdings Climbs 18%

Shares of Avaya Holdings Corp. (AVYA), a provider of digital communications products and services, are gaining more than 18 percent or $1.95 in Monday's morning trade at $12.42. The stock has traded in a range of $6.13 to $15.30 in the past 52 weeks.

from RTT - Earnings https://ift.tt/3fNNnV0
via IFTTT

Stock Alert: MyoKardia Shares Surge 80% On Phase 3 EXPLORER-HCM Trial Data

Shares of MyoKardia Inc. (MYOK) are soaring over 80% in pre-market today, after the company announced positive topline data from its Phase 3 pivotal EXPLORER-HCM clinical trial of mavacamten for the treatment of patients with symptomatic, obstructive hypertrophic cardiomyopathy (HCM).

from RTT - Before the Bell https://ift.tt/2Wp78up
via IFTTT

Marriott International Q1 Profit Falls, Misses View; But Revenue Beats

Marriott International, Inc. on Monday reported a 92 percent plunge in profit for the first quarter from last year, reflecting lower revenues and impairment charges as a result of the COVID-19 pandemic. Adjusted earnings missed analysts' expectations, while revenues beat their estimates. Marriott said it is now seeing improving occupancy trends in Greater China.

from RTT - Earnings https://ift.tt/2zpopui
via IFTTT

Stock Alert: Cardinal Health Shares Up 7% In Premarket On Upbeat Q3

Shares of Cardinal Health Inc. (CAH) are rising over 7% in pre-market today, after the healthcare company reported better-than-expected Q3 results and reaffirmed its fiscal 2020 guidance.

from RTT - Before the Bell https://ift.tt/2WJwamR
via IFTTT

Concerns About Second Wave Of Coronavirus Cases May Weigh On Wall Street

The major U.S. index futures are currently pointing to a sharply lower opening on Monday, with stocks likely to give back ground following the rally seen last week.

from RTT - Market Analysis https://ift.tt/2WjRMHn
via IFTTT

Stock Alert: Coty Shares Up 12% In Premarket On KKR Investment News

Shares of Coty Inc. (COTY) are rising over 12% in pre-market today, after the company announced a $750 million convertible preferred equity investment from KKR.

from RTT - Before the Bell https://ift.tt/2WRb32a
via IFTTT

PulteGroup To Lay Off, Furlough Employees; Sees Q2 Charge Of About $10 Mln

PulteGroup, Inc. (PHM) on Monday provided an update on actions it has taken in response to the COVID-19 pandemic. The home builder plans to reduce its targeted overhead expense through a combination of layoffs, furloughs and other cost cutting initiatives, and expects to incur a second-quarter charge of about $10 million for severance and related expenses.

from RTT - Earnings https://ift.tt/2xSJJIj
via IFTTT

FDA Approves First Antigen Test To Detect Coronavirus

The U.S. Food and Drug Administration issued the first emergency use authorization or EUA to Quidel Corp.'s COVID-19 antigen test. The Sofia 2 SARS Antigen FIA test will be used for the rapid detection of the coronavirus and is considered to play a critical role in the fight against the COVID-19 pandemic.

from RTT - Biotech https://ift.tt/2yOAKIz
via IFTTT

Cardinal Health Q3 Results Top Estimates, Reaffirms FY20 Outlook - Quick Facts

Healthcare company Cardinal Health (CAH) reported that its net earnings attributable to the company for the third quarter grew to $350 million or $1.19 per share from $296 million or $0.99 per share in the prior year.

from RTT - Earnings https://ift.tt/2zp7A2C
via IFTTT

Continental Resources Withdraws FY20 Outlook - Quick Facts

While reporting its financial results for the first quarter on Monday, Continental Resources, Inc. (CLR) said it is withdrawing all previously issued guidance for fiscal 2020 and suspending further guidance.

from RTT - Earnings https://ift.tt/2SRvomM
via IFTTT

Entergy Maintains FY20 Adj. EPS Outlook - Quick Facts

While reporting its financial results for the fourth quarter on Wednesday, integrated energy company Entergy Corp. (ETR) maintained its adjusted earnings guidance for the full year 2020.

from RTT - Earnings https://ift.tt/3fCS0RE
via IFTTT

ON Semiconductor Guides Q1 Revenue Below Estimates - Quick Facts

While reporting financial results for the first quarter on Monday, ON Semiconductor Corp. (ON) said it expects revenues in a range of $1.10 billion to $1.26 billion for the second quarter, based on product booking trends, backlog levels, and estimated turns levels.

from RTT - Earnings https://ift.tt/2LfAyEM
via IFTTT

Zimmer Biomet Suspends FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Monday, musculoskeletal healthcare company Zimmer Biomet Holdings Inc. (ZBH) it is not providing full-year 2020 financial guidance, due the uncertainty around the scope and duration of COVID-19 and its ongoing impact on the deferral of elective procedures.

from RTT - Earnings https://ift.tt/2LjJtoE
via IFTTT

Rupert Murdoch Gives Up Annual Cash Bonus

News Corp. Executive Chairman Rupert Murdoch has voluntarily forgone his entire cash bonus for fiscal 2020 following the impact of the COVID-19 pandemic on the media company's financial results. Thursday, News Corp. reported a net loss of $1 billion for the third quarter, reflecting a write-down in the value of its Australian Pay-TV operator Foxtel.

from RTT - Earnings https://ift.tt/2SQmfuG
via IFTTT

Stock Alert: Inphi Up 8% On Q1 Results, Outlook

Shares of Inphi Corp. (IPHI), a provider of analog and mixed signal semiconductor solutions, are rising more than 8 percent or $8.43 in Friday's morning trade at $107.40 after the company's net loss for the first quarter narrowed and it provided an upbeat outlook for the second quarter. The stock has traded in a range of $39.34 to $116.98 in the past 52 weeks.

from RTT - Earnings https://ift.tt/3drUznz
via IFTTT

Stock Alert: Roku Down 6%; Expects Ad Revenue Growth To Slowdown Amid Covid-19

Shares of Roku Inc. (ROKU) are currently slipping over more 6% on Friday morning after the video streaming platform shared a downbeat outlook for ad revenues going forward.

from RTT - Earnings https://ift.tt/2yGFgZr
via IFTTT

Stock Alert: Camping World Holdings Rises 22%

Shares of Camping World Holdings, Inc. (CWH), an outdoor and camping retailer, are gaining more than 22 percent or $2.45 in Friday's morning trade at $13.26, after the company reported a loss for the first quarter that narrowed from last year.

from RTT - Earnings https://ift.tt/3dnqjKs
via IFTTT

Traders Seem To View Dismal Jobs Data As Old News

The major U.S. index futures are currently pointing to a higher opening on Friday, with stocks likely to extend the strong upward move seen in the previous session.

from RTT - Market Analysis https://ift.tt/2WewxGT
via IFTTT

Stock Alert: Fortress Biotech Shares Up 17% In Premarket

Shares of Fortress Biotech Inc. (FBIO) are rising over 17% in pre-market today, after the company announced that its partner company Oncogenuity Inc. has entered into an exclusive worldwide licensing agreement with Columbia University to develop novel oligonucleotides for the treatment of genetically driven cancers.

from RTT - Before the Bell https://ift.tt/2SKE8uG
via IFTTT

Stock Alert: Ubiquiti Shares Up 13% In Premarket On Upbeat Q3

Shares of Ubiquiti (UI) are rising over 13% in pre-market today, following the company's better-than-expected Q3 results.

from RTT - Before the Bell https://ift.tt/2zkoSxW
via IFTTT

PPL Corp. Says FY20 Earnings Outlook Unchanged - Quick Facts

While reporting its first-quarter financial results on Friday, PPL Corp. (PPL) said that through the end of the first quarter, it remained on track to achieve its fiscal 2020 earnings forecast of $2.40 to $2.60 per share.

from RTT - Earnings https://ift.tt/2SM9Yai
via IFTTT

FDA Approves RedHill's COVID-19 Clinical Study With Opaganib; Stock Up 9%

Shares of RedHill Biopharma Ltd. (RDHL) are moving up over 9% in pre-market today, after the company announced that the U.S. FDA has approved its Investigational New Drug or IND application for a Phase 2a clinical study evaluating its investigational drug, opaganib, in patients with confirmed moderate-to-severe SARS-CoV-2 infection, the cause of COVID-19.

from RTT - Before the Bell https://ift.tt/3dtiqU8
via IFTTT

Meridian Bioscience Boosts FY19 Adj. EPS Outlook - Quick Facts

While reporting financial results for the second quarter on Friday, life science company Meridian Bioscience, Inc. (VIVO) raised its adjusted earnings and revenue guidance for the full year 2020, despite the turmoil of the COVID-19 pandemic due to the unprecedented demand for its Life Science products.

from RTT - Earnings https://ift.tt/3fxpot2
via IFTTT

Alliance Resource Partners Says Q2 Results Will Suffer Due To COVID-19 Pandemic

While reporting its first-quarter financial results on Friday, Alliance Resource Partners LP (ARLP) said its second-quarter results will suffer due to the demand destruction caused by the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/2SMzPiA
via IFTTT

E. W. Scripps Q1 Loss Widens, Revenue Up 47.5% - Quick Facts

E W Scripps Co. (SSP) on Friday reported net loss for the first quarter of $11.8 million or $0.15 per share, wider than net loss of $6.8 million or $0.08 per share. The company noted that its first-quarter financial results were affected by the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/2YJTbbV
via IFTTT

Stock Alert: Pluristem Shares Up 24% In Premarket On FDA Clearance News

Shares of Pluristem Therapeutics Inc. (PSTI) are rising over 24% in pre-market today, after the company announced that the U.S. FDA has cleared the company's Investigational New Drug or IND application for a Phase II study of its PLX cells in the treatment of severe COVID-19 cases complicated by Acute Respiratory Distress Syndrome or ARDS.

from RTT - Before the Bell https://ift.tt/3foJN3g
via IFTTT

Avista Lowers FY20 EPS Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Friday, energy company Avista Corp. (AVA) said it is lowering its consolidated earnings guidance for the full-year 2020 to reflect regulatory items, expected net impacts from COVID-19, and losses at our non-utility businesses.

from RTT - Earnings https://ift.tt/3dsWJUa
via IFTTT

Northwest Natural Expects FY20 EPS Towards Lower End Of Prior Outlook Range

While reporting financial results for the first quarter on Friday, Northwest Natural Holding Co. (NWN) on Friday reaffirmed its earnings from continuing operations guidance for the full-year 2020, but now expected toward the lower end of the range given potential effects from the COVID-19.

from RTT - Earnings https://ift.tt/2SKov6u
via IFTTT

HMS Holdings Trims FY20 Revenue Outlook - Quick Facts

While reporting financial results for the first quarter on Friday, cost containment solutions provider HMS Holdings Corp. (HMSY) trimmed its revenue outlook for the full year 2020.

from RTT - Earnings https://ift.tt/3bi382O
via IFTTT

Dentsply Sirona Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the third quarter on Thursday, dental solutions company Dentsply Sirona, Inc. (XRAY) said it is withdrawing its previously communicated financial guidance for the full-year 2020 as a result of the uncertainty around the duration of the COVID-19 pandemic and its impact on the business.

from RTT - Earnings https://ift.tt/3fFvV50
via IFTTT

Interface Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Friday, commercial flooring company Interface, Inc. (TILE) said it has withdrawn its previously communicated financial guidance for the full-year 2020, due to the continued disruption of the global economy due to COVID-19, and the significant level of uncertainty created by the global pandemic.

from RTT - Earnings https://ift.tt/2WeTsSH
via IFTTT

Hain Celestial Q3 Profit From Cont. Ops. Surges; Raises FY20 Earnings Outlook

Hain Celestial Group, Inc. (HAIN), an organic and natural products company, on Thursday reported net income from continuing operations for the third quarter of $25.04 million or $0.24 per share, up sharply from $8.78 million or $0.08 per share in the prior-year period.

from RTT - Earnings https://ift.tt/2YEqD3z
via IFTTT

Insight Enterprises Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Thursday, technology company Insight Enterprises, Inc. (NSIT) said it is withdrawing its 2020 financial guidance for net sales and adjusted earnings per share due to the high level of economic uncertainty and disruption caused by COVID-19.

from RTT - Earnings https://ift.tt/2WdCZhr
via IFTTT

Bristol-Myers Q1 Results Beat View; Cuts 2020 GAAP Profit Outlook

Biopharmaceutical company Bristol-Myers Squibb Co. (BMY) reported a loss in the first quarter, compared to profit last year. The company cut its GAAP earnings per share and revenue outlook for fiscal year 2020. But it reaffirmed annual adjusted profit guidance.

from RTT - Earnings https://ift.tt/35CsveE
via IFTTT

Cooper Tire & Rubber Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Thursday, tire maker Cooper Tire & Rubber Co. (CTB) said it is withdrawing its previously announced financial guidance issued on February 24 for the full-year 2020, due to the rapidly evolving environment and continued uncertainties resulting from the coronavirus (COVID-19) pandemic.

from RTT - Earnings https://ift.tt/2SIFTZu
via IFTTT

Stericycle Withdraws FY20 Outlook - Quick Facts

While reporting financial results for the first quarter on Thursday, Stericycle, Inc. (SRCL) said it is withdrawing its financial guidance for the full-year 2020 communicated on February 27, 2020, due to the magnitude and duration of the uncertain economic outlook in light of the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/35Cok2s
via IFTTT

Charles River Labs Cuts FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Thursday, Charles River Laboratories International, Inc. (CRL) slashed its earnings and revenue growth guidance for the full-year 2020, due to the global COVID-19 pandemic and its expected impact on the operations, client demand, and financial results.

from RTT - Earnings https://ift.tt/3drXsoi
via IFTTT

Telefonica Withdraws FY20 View, To Form UK JV With Liberty Global; Stock Dips

Shares of Telefonica SA were losing around 2 percent in the trading in Spain after the telecom major on Thursday reported weak first-quarter profit and withdrew fiscal 2020 guidance due to the current level of uncertainty amid Covid-19 impact. However, for the mid-term, the company backed 2022 guidance of revenue growth. Separately, Telefonica announced an agreement with Liberty Global.

from RTT - Earnings https://ift.tt/35C1RCG
via IFTTT

Quanta Services Slashes FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Thursday, Quanta Services, Inc. (PWR) slashed its earnings and revenue guidance for the full-year 2020, reflecting the estimated impact of COVID-19 and other factors on operations.

from RTT - Earnings https://ift.tt/3fq3x6B
via IFTTT

Raytheon Technologies Suspends FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Thursday, aerospace and defense company Raytheon Technologies Corp. (RTX) said it is not providing an outlook at this time, due to the ongoing uncertainty regarding the scope, severity and duration of the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/3ce2cxQ
via IFTTT

AES Lowers FY20 Adj. EPS Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Thursday, power company AES Corp. (AES) lowered its adjusted earnings guidance for the full-year 2020, due to the COVID-19-related economic slowdown.

from RTT - Earnings https://ift.tt/2L7EAPp
via IFTTT

Becton, Dickinson And Co. Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the second quarter on Thursday, medical technology company Becton, Dickinson and Co. or BD (BDX) said it is withdrawing its previously issued revenue and earnings per share guidance for the full-year 2020, due to ongoing uncertainty regarding the scope and duration of the COVID-19 global pandemic, as well as the timing and pace of recovery.

from RTT - Earnings https://ift.tt/35FNFZt
via IFTTT

Will Krystal (KRYS) Continue To Shine?

Shares of Krystal Biotech Inc. (KRYS) have now more than doubled in value since touching a 52-week low of $22.02 on June 14, 2019.

from RTT - Biotech https://ift.tt/3fwAu1w
via IFTTT

BT suspends dividend to free up 5G and broadband investment

Firm unclear as to exact cost of coronavirus pandemic but now faces challenge from O2-Virgin Media merger

BT has scrapped its dividend for the first time in more than a decade to free up billions to invest in building 5G and next generation full-fibre broadband across the UK.

BT, which is facing a new rival after the owners of Virgin Media and O2 announced a £31bn merger earlier on Thursday, reported a 12% fall in pre-tax profits to £2.3bn for the year to the end of March.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/35FDzHU

Virgin Media and O2 owners confirm £31bn mega-merger in UK

Tie-up between parent groups Liberty Global and Telefonica aim to take on BT and Sky

The owners of Virgin Media and O2 have confirmed a £31bn merger to create a new “national champion” to challenge BT and Sky in the UK.

Liberty Global, which owns the UK’s largest cable company Virgin, and Telefonica, which owns Britain’s biggest mobile operator O2, are to be merged in a new 50-50 joint venture.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2zYIoAb

Hecla Mining Reduces 2020 Capex By 25% - Quick Facts

While reporting its first-quarter financial results on Thursday, Hecla Mining Co. (HL) said that amid the COVID-19 pandemic, four out of its five mines are operating, representing 95 percent of Hecla's production. There are no known cases of COVID-19 at any of Hecla's sites.

from RTT - Earnings https://ift.tt/2yDzbNk
via IFTTT

Rathbone Brothers Q1 Underlying Net Operating Income Down 0.8%

Rathbone Brothers Plc. (RAT.L) reported Thursday that its underlying operating income for the first quarter declined 0.8 percent to 84.6 million pounds from 85.3 million pounds in the year-ago period.

from RTT - Earnings https://ift.tt/3dm2iUf
via IFTTT

Intercontinental Hotels Q1 Comparable RevPAR Down 24.9% - Quick Facts

InterContinental Hotels Group plc (IHG.L, IHG) said Thursday that Group comparable RevPAR in the first quarter was down 24.9 percent. Comparable RevPAR was down 55 percent in March and is expected to be down around 80 percent in April.

from RTT - Earnings https://ift.tt/3b8C4TD
via IFTTT

Electrolux Q1 Profit Surges; Sees Significant Loss In Q2 - Quick Facts

Swedish home appliances giant Electrolux AB (0MDT.L, 0GQ1.L, ELUXY.PK) reported Thursday that its first-quarter Group income surged to 2.51 billion Swedish kronor from 79 million Swedish kronor a year ago. Earnings per share rose to 8.73 kronor from 0.28 kronor last year.

from RTT - Earnings https://ift.tt/2SJwOzq
via IFTTT

BT Group FY Profit Declines; Suspends Dividend Payments - Quick Facts

BT Group plc (BT_A.L, BT) said Thursday that its full year 2019/20 results were overall in line with expectations and it completed the 1.6 billion pounds phase 1 transformation program one year ahead of schedule.

from RTT - Earnings https://ift.tt/2WAGD3L
via IFTTT

Munich Re Q1 Profit Down 65.1% - Quick Facts

German reinsurer Munich Re (0KFE.L) reported Thursday that its profit for the first-quarter fell 65.1 percent to 221 million euros from 633 million euros in the same period last year. On a per share basis, net income was 1.57 euros, down sharply from 4.35 euros in the previous year.

from RTT - Earnings https://ift.tt/3ban5bX
via IFTTT

Anheuser-Busch InBev Slides To Loss In Q1 - Quick Facts

Anheuser-Busch InBev (AHBIF.PK, BUD) reported Thursday that its first-quarter loss attributable to equity holders was $2.25 billion or $1.13 per share, compared to restated net income of $3.57 billion or $1.80 per share in the previous-year quarter.

from RTT - Earnings https://ift.tt/2ysjHMm
via IFTTT

ArcelorMittal Slips To Loss In Q1; To Suspend Dividend Payments - Quick Facts

ArcelorMittal (MT) on Thursday reported that its first quarter net loss attributable to equity holders of the parent was $1.12 billion or $1.11 per basic share, compared to net income of $0.45 billion or $0.41 per basic share in the year-ago quarter.

from RTT - Earnings https://ift.tt/3bhRiGc
via IFTTT

FDA Decision On BMY's Drug Postponed, ENTA's PBC Study Fails, MGNX Turns Heads

Today's Daily Dose brings you news about the revised FDA decision date for Bristol Myers' CAR T cell therapy for refractory large B-cell lymphoma; Enanta Pharma's primary biliary cholangitis trial results; MacroGenics' anticipated clinical data read-outs and regulatory event for this year and Trovagene's name change.

from RTT - Biotech https://ift.tt/2xFDuaw
via IFTTT

Is Sysco Well Positioned As Restaurants Start Reopening?

Foodservice giant Sysco Corp. (SYY) has been significantly impacted by the coronavirus pandemic that has forced many of its customers such as restaurants, office cafeterias and hospitality facilities to remain temporarily closed. However, the company said it is seeing weekly improvements and expects this trend to continue. Sysco's primary customer base is the restaurant industry.

from RTT - Earnings https://ift.tt/2WyBxoL
via IFTTT

JD Sports attacks regulator for blocking Footasylum merger

Competition and Markets Authority’s ‘absurd’ decision fails to take account of coronavirus fallout, chain says

JD Sports Fashion has criticised the competition watchdog for paving the way for potential job losses after the retailer was blocked from merging with a struggling rival, Footasylum.

Peter Cowgill, the executive chairman of the UK’s largest sports retailer, said the company “fundamentally disagreed” with the Competition and Markets Authority’s decision, which was “absurd” in the light of the high street’s struggles.

Related: JD Sports stops paying rent to landlords

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/35Cnum6

Stock Alert: Activision Blizzard Rises 6%

Shares of Activision Blizzard, Inc. (ATVI) are gaining almost 6 percent or $3.95 in Wednesday's morning trade at $72.48, after the video game producer reported an increase in profit for the first quarter and raised its full-year outlook. The stock has traded in a range of $41.84 to $74.79 in the past 52 weeks.

from RTT - Earnings https://ift.tt/2W9KmXi
via IFTTT

Stock Alert: Horizon Therapeutics Up 9%

Shares of Horizon Therapeutics plc (HZNP) are rising almost 9 percent or $3.29 in Wednesday's morning trade at $40.67 on better-than-expected first-quarter results and upbeat sales outlook for the full year.

from RTT - Earnings https://ift.tt/2A5aaLz
via IFTTT

Advanced Energy Industries Q1 Profit Rises, Results Beat View

Advanced Energy Industries, Inc. (AEIS), a manufacturer of precision power conversion, measurement and control solutions, on Wednesday reported net income for the first quarter of $18.06 million or $0.47 per share, up from $15.37 million or $0.40 per share in the year-ago period.

from RTT - Earnings https://ift.tt/3cbYx3v
via IFTTT

U.S. Stocks May See Further Upside In Early Trading

The major U.S. index futures are pointing to a higher open on Wednesday, with stocks likely to extend the upward move seen over the course of the two previous sessions.

from RTT - Market Analysis https://ift.tt/3fqgX2B
via IFTTT

Owens & Minor Q1 Loss Narrows; Affirms FY20 Outlook - Quick Facts

Hospital supplier Owens & Minor, Inc. (OMI) on Wednesday reported net loss for the first quarter of $11.32 million or $0.19 per share, narrower than net loss of $14.10 million or $0.23 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/3fplwKy
via IFTTT

Blucora Withdraws First Half 2020 Tax Preparation Outlook - Quick Facts

While reporting financial results for the first quarter on Wednesday, financial technology company Blucora, Inc. (BCOR) said it is withdrawing its prior first half 2020 tax preparation outlook and not providing additional outlook guidance at this time amid the COVID-19 outbreak.

from RTT - Earnings https://ift.tt/3fm7ppr
via IFTTT

Gibraltar Industries Q1 Profit Beats View; Cancels FY20 Outlook

Gibraltar Industries, Inc. (ROCK), a manufacturer and distributor of building products and services, on Wednesday reported a 92.1 percent surge in profit for the first quarter from last year.

from RTT - Earnings https://ift.tt/2WvvaCB
via IFTTT

FLIR Systems Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Wednesday, industrial technology company FLIR Systems, Inc. (FLIR) said it is withdrawn its previously issued earnings and revenue guidance for the full-year 2020 as the magnitude and duration of the COVID-19 outbreak, including its impact to FLIR's operations, supply chain partners and customers, remains uncertain.

from RTT - Earnings https://ift.tt/2Wvylu9
via IFTTT

General Motors Q1 Profit Falls, But Results Beat View - Quick Facts

Automaker General Motors Co. (GM) on Wednesday reported first-quarter net income attributable to shareholders of $294 million or $0.17 per share, down sharply from $2.16 billion or $1.48 per share in the year-ago period, as results were impacted by the coronavirus pandemic.

from RTT - Earnings https://ift.tt/2YH5GVA
via IFTTT

Scotts Miracle-Gro Boosts FY20 Sales Growth Outlook - Quick Facts

While reporting financial results for the second quarter on Wednesday, Scotts Miracle-Gro Co. (SMG) maintained its adjusted earnings guidance for the full-year 2020, while raising sales growth outlook.

from RTT - Earnings https://ift.tt/2A4SpvT
via IFTTT

Israel-based Ayala Pharma To Debut On Nasdaq On May 7

Israel-based Ayala Pharmaceuticals is slated to debut on the Nasdaq Global Select Market, under the symbol 'AYLA', on May 7, 2020.

from RTT - Biotech https://ift.tt/3cagTSl
via IFTTT

Stock Alert: Medigus Stock Up 41% In Premarket

Shares of Medigus Ltd. (MDGS) are rising over 41% in pre-market today, after the company announced that Polyrizion has filed a US patent application for formulations and methods for preventing viral infections by COVID-19 virus.

from RTT - Before the Bell https://ift.tt/2A4RqvG
via IFTTT

BMW Q1 Net Profit Down; Warns On FY20 Earnings, Margin; Stock Dips

Shares of BMW AG were losing around 3 percent in the German trading after the luxury carmaker on Wednesday reported weak net profit in its first quarter, and warned about significant drop in fiscal 2020 profit before tax due to the negative impact of the worldwide corona crisis.

from RTT - Earnings https://ift.tt/3caAmm8
via IFTTT

Zoetis Slashes FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Wednesday, animal health company Zoetis Inc. (ZTS) slashed its earnings and revenue guidance for the full year 2020 to reflect its current view of the estimated full-year impact of the COVID-19 outbreak, recessionary conditions in the global economy, and foreign currency headwinds.

from RTT - Earnings https://ift.tt/2YDp4mo
via IFTTT

Office Depot Withdraws FY20 Outlook; Suspends Share Buyback, Dividend

While reporting financial results for the first quarter on Wednesday, Office Depot Inc. (ODP) said it is withdrawing its previously issued guidance for the full-year 2020, due to the global business disruption and uncertainty caused by the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/2YFAuWY
via IFTTT

Stock Alert: CPS Technologies Stock More-Than-Doubles In Premarket

Shares of CPS Technologies Corp. (CPSH) are rising sharply over 105% in pre-market today, following the company strong Q1 results.

from RTT - Before the Bell https://ift.tt/3bdwqQ1
via IFTTT

Myers Industries Withdraws FY20 EPS Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Wednesday, polymer products maker Myers Industries, Inc. (MYE) said it is withdrawing its earnings per share guidance for the full-year 2020 that was provided during its fourth quarter 2019 earnings call.

from RTT - Earnings https://ift.tt/2WwLQK3
via IFTTT

BorgWarner Slashes FY20 Net Sales Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Wednesday, technology solutions provider BorgWarner Inc. (BWA) slashed its net sales guidance for the full-year 2020 as global light vehicle production expectations remain volatile due to the impact of coronavirus (COVID-19).

from RTT - Earnings https://ift.tt/3b9T7VB
via IFTTT

Bunge Trims FY20 EPS Outlook, Now Sees It Lower Than 2019 - Quick Facts

While reporting financial results for the first quarter on Wednesday, agribusiness and food company Bunge Ltd. (BG) said its earnings per share for the full-year 2020 is now projected to be lower than its original expectation communicated on February 12, 2020, based on the current market environment and forward curves as there is little visibility into the second half of the year amid the COVID-19 outbreak.

from RTT - Earnings https://ift.tt/2zdcOOP
via IFTTT

Vapotherm's (VAPO) Journey From $9 To $22 In 6 Months, More In Store?

These are exciting times for Vapotherm Inc. (VAPO) whose share price has almost doubled in value since the beginning of this year.

from RTT - Biotech https://ift.tt/3c8sSQF
via IFTTT

ARDS In COVID-19 Battle, AKBA's Kidney Disease Drug Hits Goals, VAPO On A Roll

Today's Daily Dose brings you news about the acquisition of Portola by Alexion; encouraging results from TG Therapeutics' chronic lymphocytic leukemia trial; Akebia's INNO2VATE trial results; and Vapotherm's Q1 financial results.

from RTT - Biotech https://ift.tt/2YBxoD4
via IFTTT

Black Knight Q1 Profit Beats View; Lowers FY20 Outlook - Quick Facts

Black Knight, Inc. (BKI), a provider of software, data and analytics solutions, reported Tuesday that its net earnings for the first quarter surged to $50.1 million or $0.34 per share from $26.0 million or $0.18 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/3dhsAqI
via IFTTT

Futures Pointing To Initial Strength On Wall Street

The major U.S. index futures are currently pointing to a higher open on Tuesday, with stocks likely to extend the rebound seen over the course of the previous session.

from RTT - Market Analysis https://ift.tt/2WsuiyO
via IFTTT

FDA Clears 1st Product Derived From Amniotic Fluid To Enter COVID-19 Trial

Organicell Regenerative Medicine Inc. (BPSR.OB) has received FDA clearance to initiate a phase I/II multi-center clinical trial of Organicell Flow in patients diagnosed with moderate to severe acute respiratory syndrome (SARS) due to COVID-19 infection.

from RTT - Biotech https://ift.tt/2WAdjL4
via IFTTT

Stock Alert: Genprex Shares Up 53% In Premarket

Shares of Genprex Inc. (GNPX) are surging over 53% in pre-market today, after the company announced a Patent and Technology License Agreement with The University of Texas MD Anderson Cancer Center for combination of its TUSC2 gene therapy with immunotherapies.

from RTT - Before the Bell https://ift.tt/2zfgsrj
via IFTTT

Expeditors Intl. Expects Disruptions From COVID-19 For Remainder Of 2020

While reporting its first-quarter financial results on Tuesday, Expeditors International of Washington, Inc. (EXPD) said it expect disruptions from COVID-19 to continue for the remainder of 2020.

from RTT - Earnings https://ift.tt/35x0a9D
via IFTTT

Lancaster Colony Q3 Profit Declines, Revenue Rises - Quick Facts

Lancaster Colony Corp. (LANC), a maker of specialty food products, Tuesday reported that its net income for the third quarter declined to $22.43 million or $0.81 per share from $30.60 million or $1.11 per share in the year-ago period.

from RTT - Earnings https://ift.tt/2W9HOsh
via IFTTT

IPG Photonics Guides Q2 In Line With Estimates - Quick Facts

While reporting financial results for the first quarter on Tuesday, IPG Photonics Corp. (IPGP) provided earnings and revenues guidance for the second quarter, in line with analysts' estimates.

from RTT - Earnings https://ift.tt/2xCm2nt
via IFTTT

Illinois Tool Works Suspends FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Tuesday, Illinois Tool Works Inc. (ITW) said it is suspending its previously announced financial guidance for the full-year 2020, due to uncertainties regarding the duration and severity of the coronavirus (COVID-19) pandemic.

from RTT - Earnings https://ift.tt/2ymRSFc
via IFTTT

Kopin Says AR Headset Products Being Using During COVID-19 Pandemic

While reporting its first-quarter financial results on Tuesday, Kopin Corp. (KOPN), a provider of wearable computing technologies, noted that its Augmented Reality or AR headset customers have reported their products are being used in hospitals and areas of high infection by medical and public safety responders amid the COVID-19 crisis.

from RTT - Earnings https://ift.tt/2Yy7ksF
via IFTTT

Allegheny Technologies Withdraws FY20 Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Tuesday, Allegheny Technologies Inc. (ATI) said it is withdrawing its financial guidance for the full-year 2020, due to the current market uncertainty amid the ongoing COVID-19 pandemic.

from RTT - Earnings https://ift.tt/2WuH4wz
via IFTTT

Tetra Technologies Hopes To Benefit From European Industrial Chemicals Business

While reporting its financial results for the first quarter on Tuesday, Tetra Technologies, Inc. (TTI) said that despite the challenging economic outlook for 2020, especially for oil and gas, it expect the non-oil and gas industrial business to hold up well for the foreseeable future.

from RTT - Earnings https://ift.tt/2A2eCL1
via IFTTT

Medifast Recalls Optavia Oatmeal For Undeclared Milk

Baltimore, Maryland-based Medifast, Inc. is recalling certain Optavia Oatmeal products citing undeclared milk, a known allergen, the U.S. Food and Drug Administration said in a statement. The recall involves around 24,923 boxes of OPTAVIA Essential Old Fashioned Maple & Brown Sugar Oatmeal. The product is packaged in yellow and white cardboard boxes with the brand name.

from RTT - Biotech https://ift.tt/2KYd5b8
via IFTTT

Group 1 Automotive Sees Q2 Results Significantly Lower Than Last Year

While reporting financial results for the first quarter on Tuesday, Group 1 Automotive Inc. (GPI) expects its second quarter results to be significantly lower than the prior year, while the potential long-term impact of COVID-19 pandemic is difficult to predict.

from RTT - Earnings https://ift.tt/2zh3BF5
via IFTTT

Incyte Slips To Loss In Q1, Despite Higher Revenues - Quick Facts

Incyte Corp. (INCY) on Tuesday reported a net loss for the first quarter of $720.64 million or $3.33 per share, compared to net income of $102.31 million or $0.47 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/35wXSXO
via IFTTT

TransDigm Expects COVID-19 Pandemic To Adversely Impact Remainder Of FY20

While reporting its second-quarter financial results on Tuesday, TransDigm Group Inc. (TDG) said it currently expects the COVID-19 pandemic to have a significant adverse impact on its sales, EBITDA and net income for the remainder of fiscal 2020.

from RTT - Earnings https://ift.tt/2ysAwGI
via IFTTT

Fiat Chrysler Automobiles Reports Positive Adj. EBIT In Q1; Revenues Down 16%

Fiat Chrysler Automobiles (FCAU) reported a first quarter net loss from continuing operations of 1.69 billion euros compared to profit of 508 million euros, prior year. Loss per share from continuing operations was 1.08 euros compared to profit of 0.32 euros. Adjusted net loss was 471 million euros compared to profit of 570 million euros, a year ago. Adjusted loss per share was 0.30 euros compared to profit of 0.36 euros. Adjusted EBIT was at 52 million euros, for the quarter.

from RTT - Earnings https://ift.tt/3dmsQ7Z
via IFTTT

Sealed Air Suspends FY20 Outlook Amid COVD-19 - Quick Facts

While reporting financial results for the first quarter on Tuesday, packaging company Sealed Air Corp. (SEE) said it is suspending its financial guidance for the full-year 2020, given the uncertainty in the markets we serve amid the COVID-19 outbreak.

from RTT - Earnings https://ift.tt/2LexKbb
via IFTTT

A.O. Smith Suspends FY20 Outlook, Share Buyback Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Tuesday, water technology company A.O. Smith Corp. (AOS) said it is suspending its financial guidance for the full-year 2020, as it believes the current environment does not allow it to forecast performance with reasonable precision.

from RTT - Earnings https://ift.tt/35A5x7V
via IFTTT

Vishay Precision Guides Q2 Revenues In Line With Estimates - Quick Facts

While reporting its financial results for the first quarter on Tuesday, technology company Vishay Precision Group, Inc. (VPG) provided net revenue guidance for the second quarter of fiscal 2020, given the effects of the COVID-19 pandemic.

from RTT - Earnings https://ift.tt/3b7A3qW
via IFTTT

Thomson Reuters Slashes FY20 Revenue Growth Outlook Amid COVID-19 - Quick Facts

While reporting financial results for the first quarter on Tuesday, Thomson Reuters Corp. (TRI, TRI.TO) slashed its revenue and organic revenue growth guidance for the full-year 2020, to reflect its currently estimated impact of the COVID-19 pandemic. It also provided revenue growth outlook for the second quarter.

from RTT - Earnings https://ift.tt/2zVO0uZ
via IFTTT

Hawaiian Electric Q1 Results Miss Estimates; Declares Dividend - Quick Facts

Hawaiian Electric Industries Inc (HE) reported Tuesday that its first-quarter net income was $33.42 million or $0.31 per share, lower than $45.69 million or $0.421 per share in the prior-year quarter. Total revenues for the quarter increased to $597.44 million from last year's $578.50 million.

from RTT - Earnings https://ift.tt/2A1h98g
via IFTTT

Haemonetics Not Issuing FY21 Outlook At This Time Amid COVID-19 - Quick Facts

While reporting financial results for the fourth quarter on Tuesday, healthcare company Haemonetics Corp. (HAE) said it is not issuing guidance for the full-year 2020 at this time, due to the uncertainty around the full impact and duration of the COVID-19 pandemic, and the nature and timing of the associated economic recovery.

from RTT - Earnings https://ift.tt/2SzNvx5
via IFTTT

DuPont Provides Update On COVID-19 Impact On Business - Quick Facts

While reporting financial results for the first quarter on Tuesday, DuPont (DD) said it has issued $2.0 billion bond to refinance debt maturities due in November 2020 and replaced the $2.0 billion 364-day delayed-draw facility.

from RTT - Earnings https://ift.tt/2WqvIcY
via IFTTT

Stock Alert: Tyson Foods Down 6% As Q2 Results Miss Street

Shares of Tyson Foods Inc. (TSN) tanked 6% on Monday morning trade after the meat products maker reported a second-quarter profit and sales that missed Wall Street estimates.

from RTT - Earnings https://ift.tt/2SvVuez
via IFTTT

Stock Alert: PG&E Corp. Rises 4%

Shares of PG&E Corp (PCG) are rising more than 4 percent or $0.43 in Monday's morning trade at $10.57. The stock has traded in a range of $3.55 to $25.19 in the past 52 weeks.

from RTT - Earnings https://ift.tt/3bXWShU
via IFTTT

Stock Alert: Applied DNA Sciences Stock Surges 94% In Premarket

Shares of Applied DNA Sciences Inc. (APDN) are soaring over 94% in pre-market today, after the company and Takis Biotech announced the production of neutralizing antibodies against SARS-CoV-2 after DNA vaccination in animals.

from RTT - Before the Bell https://ift.tt/2zbbiNm
via IFTTT

National Retail Properties Q1 Profit Declines, Misses View; But Revenues Beat

National Retail Properties, Inc. (NNN), a real estate investment trust, on Monday reported a decline in profit for the first quarter from last year despite higher revenues. Earnings per share missed analysts' expectations, while revenue beat their estimates.

from RTT - Earnings https://ift.tt/2zX7eR6
via IFTTT

Rising U.S.-China Tensions May Generate Early Selling Pressure

The major U.S. index futures are currently pointing to a lower opening on Monday, with stocks likely to extend the sharp pullback seen over the two previous sessions.

from RTT - Market Analysis https://ift.tt/3c44nDU
via IFTTT

Stock Alert: Stemline Stock Climbs 153% In Premarket On Acquisition News

Biopharmaceutical company Stemline Therapeutics Inc. (STML) is currently trading at $12.02, up $7.27 or 153.05% in the pre-market session. The stock has been trading between $3.21 and $18.22 in the past one year, and closed Friday's trade at $4.75, down 62 cents or 11.55%. STML

from RTT - Before the Bell https://ift.tt/3bXleIF
via IFTTT

Junshi, Eli Lilly Agree To Co-develop JS016 Antibodies Against COVID-19

Junshi Biosciences, a China-based biopharmaceutical company, and Eli Lilly and Company (LLY) have entered into an agreement to co-develop therapeutic antibodies for the potential prevention and treatment of COVID-19. Junshi SARS-CoV-2 Antibodies, or JS016, is a recombinant fully human monoclonal neutralizing antibody that is specific to the SARS-CoV-2 surface spike protein receptor binding domain. It is jointly developed by Junshi Biosciences and Institute of Microbiology, Chinese Academy of Science.

from RTT - Biotech https://ift.tt/35AwOHh
via IFTTT

PetMed Express Q4 Results Top Estimates; Boosts Dividend - Quick Facts

PetMed Express, Inc. (PETS) reported Monday that fourth quarter net income grew to $7.0 million or $0.35 per share from $6.6 million or $0.32 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/2SAHOz5
via IFTTT

Lupin Pharma: Phase 3 Trial Of Single-Dose Solosec Met Primary Endpoint

Lupin Pharmaceuticals Inc. (LUPIN, 500257) on Monday announced positive top-line results from its pivotal Phase 3 clinical trial to assess the efficacy and safety of single-dose Solosec or secnidazole 2g oral granules in 147 female patients with trichomoniasis.

from RTT - Biotech https://ift.tt/3b3aUh5
via IFTTT

Vir Biotechnology, Alnylam Identify VIR-2703 Candidate For Treatment Of COVID-19

Vir Biotechnology, Inc. (VIR) and Alnylam Pharmaceuticals, Inc. (ALNY) announced Monday that they have selected a development candidate (DC) for VIR-2703 (ALN-COV), an investigational RNAi therapeutic targeting the SARS-CoV-2 (COVID-19) genome.

from RTT - Biotech https://ift.tt/2KZSrqW
via IFTTT

Pitney Bowes Suspends FY20 Outlook, But Declares Cash Dividend - Quick Facts

While reporting its financial results for the first quarter on Monday, technology company Pitney Bowes (PBI) said it is suspending guidance for the current financial year of 2020, based on the level of uncertainty around the depth and duration of the Covid-19 outbreak.

from RTT - Earnings https://ift.tt/2VYyAPf
via IFTTT

Sempra Energy Reaffirms FY20, FY21 Outlook - Quick Facts

While reporting financial results for the first quarter on Monday, energy infrastructure company Sempra Energy (SRE) reaffirmed its adjusted earnings guidance for the full-year 2020, and earnings outlook for the full-year 2021.

from RTT - Earnings https://ift.tt/2SzhbdV
via IFTTT

Loews Slips To Loss In Q1 - Quick Facts

Loews Corp. (L) on Monday reported a first-quarter net loss of $632 million or $2.20 per share, compared to net income of $394 million or $1.27 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/3b21NNJ
via IFTTT

Berkshire Posts Nearly $50 Bln Loss In Q1

Billionaire Warren Buffett's Berkshire Hathaway Inc. (BRK.A, BRK.B) on Saturday reported a loss of nearly $50 bln for the first-quarter, hurt by $55.5 billion in unrealized losses in the massive stock portfolio. But, quarterly operating earnings increased about 5.6 percent.

from RTT - Earnings https://ift.tt/3d76maQ
via IFTTT

Gilead's Remdesivir Becomes 1st Drug Allowed For Emergency Use For COVID-19

The FDA has issued emergency use authorization for Gilead Science Inc's (GILD) antiviral drug Remdesivir for the treatment of COVID-19 in adults and children hospitalized with severe disease.

from RTT - Biotech https://ift.tt/2xrAwq1
via IFTTT

Virgin and O2 plan merger to challenge Sky and BT

Owners of telecoms giants set to team up and challenge major sector players

The owners of Virgin Media and O2 are in talks to create a new TV and mobile power player to challenge BT and Sky in the UK.

Billionaire John Malone’s Liberty Global, which owns Virgin Media and a 10% stake in ITV, is understood to be in talks with Spanish telecoms giant Telefonica to combine their UK assets in a joint venture.

Continue reading...

from Mergers and acquisitions | The Guardian https://ift.tt/2YqiZK6

Stock Alert: Dow Loses 6% After Q1 Profit Falls

Shares of Dow Inc. (DOW), a provider of materials science solutions for the consumer care, infrastructure, and packaging markets, are losing more than 6 percent or $2.23 in Friday's morning trade at $34.46. The stock has traded in a range of $21.95 to $56.25 in the past 52 weeks.

from RTT - Earnings https://ift.tt/3d6LBvX
via IFTTT

PG&E Says On Track For Bankruptcy Court Confirmation Of Reorganization Plan

While reporting its first-quarter financial results on Friday, PG&E Corp. (PCG) said it continues to make substantial progress in reorganization cases under Chapter 11 and remains on track for Bankruptcy Court confirmation of its Plan of Reorganization by June 30, 2020. The company noted this will allow it to participate in California's new go-forward wildfire fund.

from RTT - Earnings https://ift.tt/3f2kJPo
via IFTTT